Great Point Partners LLC Puma Biotechnology, Inc. Transaction History

Great Point Partners LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $417,314 - $833,200	142,916 Added 10.64%	1,486,544 $4.85 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $1.07 Million - $1.85 Million	250,355 Added 22.9%	1,343,628 $7.12 Million
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $2.44 Million - $4.91 Million	1,093,273 New	1,093,273 $4.73 Million
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $3.71 Million - $8.55 Million	-1,300,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $1.54 Million - $2.4 Million	197,927 Added 17.96%	1,300,000 $13.3 Million
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $9.59 Million - $11.2 Million	1,009,571 Added 1091.4%	1,102,073 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $648,439 - $1.22 Million	92,502 New	92,502 $965,000
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $11.1 Million - $32.2 Million	-900,000 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$20.77 - $42.37 $9.96 Million - $20.3 Million	-479,700 Reduced 34.77%	900,000 $34.9 Million
Q4 2018 Feb 15, 2019	BUY	$20.07 - $46.7 $27.7 Million - $64.4 Million	1,379,700 New	1,379,700 $28.1 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $24.2 Million - $34.1 Million	-500,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$59.7 - $99.25 $29.9 Million - $49.6 Million	500,000 New	500,000 $0

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $123M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.